Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome - PCORI
Led by Ann & Robert H Lurie Children's Hospital of Chicago · Updated on 2024-07-16
4680
Participants Needed
4
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
Sponsors
A
Ann & Robert H Lurie Children's Hospital of Chicago
Lead Sponsor
P
Patient-Centered Outcomes Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
Lennox-Gastaut syndrome (LGS) is a rare and serious form of epilepsy that begins in infancy and early childhood. It causes seizures that often require emergency medical care and hospital stays, disrupting life for both the child and their family. LGS is also linked to difficulties in motor skills, communication, eating, and daily functioning. This research aims to compare two common treatments—adding more anti-seizure medications versus palliative surgery—to see which better reduces emergency visits and hospitalizations, as well as lessens developmental and functional challenges in children with LGS.
The study is observational and includes two parts. The first part involves looking back at medical records from seven pediatric hospitals to compare outcomes for children treated with either additional medications approved for LGS or palliative surgeries like neurostimulation. The second part describes how these treatments are used across 18 hospitals, analyzing differences over time and by patient characteristics such as age, medical conditions, race, ethnicity, and insurance type.
Participants' medical records will be reviewed to assess seizure-related emergency healthcare use over two years and parent-reported clinical outcomes related to function. The study also seeks to improve research methods and infrastructure for studying LGS and other rare epilepsies. The results aim to help parents and doctors make better-informed treatment decisions for children affected by this lifelong condition.
CONDITIONS
Brief Title
Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
Who Can Participate
Age: 0 - 26Years
All Genders
Eligibility Criteria
You may qualify if you...
Patients with the diagnosis of Lennox Gastaut syndrome with medical records at the seven plus eleven pediatric centers
You will not qualify if you...
Patients without Lennox Gastaut Syndrome
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
/null
Long-term Monitoring
Duration - 2 years
Participants who undergo routine care are observed for seizure-related emergency health care utilization and functional outcomes over time.
/null
Trial Site Locations
Total: 4 locations
1
Ann & Robert H. Lurie Children's Hospital of Chicago
Comparative effectiveness of epilepsy surgery versus additional anti-seizure medications for Lennox-Gastaut syndrome: study protocol for a multicenter, mixed-methods study.